← FDA Drug Approvals (Drugs@FDA)

TRELEGY ELLIPTA

NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 2017-09-18

Drug application

FDA Application #

NDA209482

Application type

New Drug Application

Brand name

TRELEGY ELLIPTA

Generic name

FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Active ingredients

FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE

Dosage form

POWDER

Route

INHALATION

Marketing status

Prescription

Sponsor

GLAXOSMITHKLINE

Manufacturer

GlaxoSmithKline LLC

First approval

2017-09-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown